Medtronic Stock News

Medtronic Plc (NYSE: MDT ) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional Atherectomy System. Recently, Medtronic issued a recall for the HawkOne Atherectomy system due to tip damage risk , Full story available on Benzinga.com

Pune, India, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The global pulse oximeters market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled "Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025," the market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period. In the report, Fortune Business Insights has profiled a few companies that are operating in the global pulse oximeter market. Some of the leading companies that have been identified as significant growth contributors are GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V, Masimo, Messe Düsseldorf GmbH, VYAIRE, Opto Circuits (India) Limited, Medtronic, Omron Healthcare, Inc., Nonin, and B Smiths Group plc. Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/pulse-oximeters-market-100528 Masimo''s Approval for Radius PPG to Trigger Growth In 2019, Masimo received clearance for its latest pulse oximeter.

Zimmer (ZBH) delivered earnings and revenue surprises of -0.51% and 0.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Medtronic's (MDT) Hugo RAS system was utilized to perform robotic prostatectomy at OLV Hospital in Aalst, Belgium.

Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional At

Medtronic's (MDT) Hugo RAS system was utilized to perform robotic prostatectomy at OLV Hospital in Aalst, Belgium.

COVID-19 has slowed down growth, but long-term prospects look very promising.

The opposite of the old adage to "buy the rumor, sell the news" doesn't apply to ShockWave.

New government program enables access to integrated hybrid closed loop technology for 18 and under BRAMPTON, ON , Feb. 3, 2022 /CNW/ - Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT ), a global leader in healthcare technology, applauds the Alberta government''s announcement of a comprehensive reimbursement program for continuous glucose monitoring (CGM) for eligible residents living with diabetes, under the age of 18. CGM devices provide critical information on glucose levels to help with the management of diabetes. Medtronic fully supports this investment in the health of young people living with diabetes, enabling access to innovative diabetes management technology to help improve control of this very challenging chronic disease. "Before I had CGM, it was all about worrying whether I could get through my day and keep my numbers in range," shares Savannah Seibel , a 17 year-old high school student and viola player from Edmonton, Alberta . "It was always there in the back of my mind.

Medtronic (MDT) is registering organic growth in the Cardiovascular, Neuroscience and Diabetes segments.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Medtronic (MDT) said the first clinical procedure in Europe with the Hugo robotic-assisted surgery ((RAS)) system was performed.The robotic prostatectomy was performed by

Medtronic (MDT) closed the most recent trading day at $103.49, moving +0.35% from the previous trading session.

Medtronic (MDT) closed the most recent trading day at $103.49, moving +0.35% from the previous trading session.

The MEDTRONIC INC. PAC successfully filed their F3XN QUATERLY YEAR-END with the coverage period of 07/01/2021 to 12/31/2021 and a confirmation ID of FEC-1562487 *********CommitteeId: C00311878 | FilingId: 1562487 | FormType: F3XN | CoverageFrom: 07/01/2021 | CoverageThrough: 12/31/2021 | ReportType: QUATERLY YEAR-END*********